Molecular Therapeutics Ceo
Molecular Therapeutics Ceo entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Tue, 04 Aug 2026 20:46:01 GMT4D Molecular Therapeutics (FDMT) CEO sells 12,415 shares via 10b5-1 plan - Stock Titan
Tue, 04 Aug 2026 07:00:00 GMT4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987 - Bitget
Related explainers
Connected entities
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Molecular Therapeutics Ceo.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.